Back
Arrowhead Pharmaceuticals Vs. CEL-SCI Industry Stock Comparison
Sell
44
ARWR
Arrowhead Pharmaceuticals
Last Price:
20.85
Seasonality Move:
32.21%
Sell
34
CVM
CEL-SCI
Last Price:
0.95
Seasonality Move:
0.42%
Sell
44
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $21.10. The Score for ARWR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
CEL-SCI (CVM)
is a Sell
Is CEL-SCI a Buy, Sell or Hold?
- The current CEL-SCI [CVM] share price is $0.99. The Score for CVM is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- CVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $21.10
The current trend is relatively stagnant and ARWR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 58.18 | Buy |
| Chaikin Money Flow: | 1621786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.55 - 20.63) | Buy |
| Bollinger Bands (100): | (20.76 - 26.98) | Sell |
CVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 37.83 | Sell |
| Chaikin Money Flow: | 137145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.15) | Sell |
| Bollinger Bands (100): | (1.07 - 1.29) | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.81 | Buy |
| 20-day SMA: | 19.34 | Buy |
| 50-day SMA: | 21.52 | Sell |
| 200-day SMA: | 26.44 | Sell |
| 8-day EMA: | 19.39 | Buy |
| 20-day EMA: | 19.61 | Buy |
| 50-day EMA: | 21.31 | Sell |
| 200-day EMA: | 25.2 | Sell |
CVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.02 | Sell |
| 20-day SMA: | 1.05 | Sell |
| 50-day SMA: | 1.1 | Sell |
| 200-day SMA: | 1.6 | Sell |
| 8-day EMA: | 1.01 | Sell |
| 20-day EMA: | 1.05 | Sell |
| 50-day EMA: | 1.11 | Sell |
| 200-day EMA: | 1.48 | Sell |
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
CEL-SCI Earnings Growth & CVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.18 per share.
Arrowhead Pharmaceuticals Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CEL-SCI Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||